Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Irma Rahayu Latarissa,1,2 Miski Aghnia Khairinisa,1 Ghina Nadhifah Iftinan,2 Anna Meiliana,1,3 Ida Paulina Sormin,4,5 Melisa Intan Barliana,6,7 Keri Lestari1,2,7 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Medication Therapy...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Latarissa IR, Khairinisa MA, Iftinan GN, Meiliana A, Sormin IP, Barliana MI, Lestari K
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2025-01-01
Edice:	Clinical Pharmacology: Advances and Applications
Témata:	randomized controlled trial quinine sulfate atovaquone artemisin-piperaquine sars-cov-2.
On-line přístup:	https://www.dovepress.com/efficacy-and-safety-of-antimalarial-as-repurposing-drug-for-covid-19-f-peer-reviewed-fulltext-article-CPAA
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!